Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation

In patients with symptomatic COPD, severe/very severe airflow limitation, and a history of one moderate (and no severe) exacerbation, ICS-containing triple therapy significantly reduces exacerbation risk overall versus single or double maintenance therapy http://ow.ly/VgJC30o9pXC

Detalles Bibliográficos
Autores principales: Singh, Dave, Fabbri, Leonardo M., Corradi, Massimo, Georges, George, Guasconi, Alessandro, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853799/
https://www.ncbi.nlm.nih.gov/pubmed/30792343
http://dx.doi.org/10.1183/13993003.00235-2019
_version_ 1783470100815282176
author Singh, Dave
Fabbri, Leonardo M.
Corradi, Massimo
Georges, George
Guasconi, Alessandro
Vezzoli, Stefano
Petruzzelli, Stefano
Papi, Alberto
author_facet Singh, Dave
Fabbri, Leonardo M.
Corradi, Massimo
Georges, George
Guasconi, Alessandro
Vezzoli, Stefano
Petruzzelli, Stefano
Papi, Alberto
author_sort Singh, Dave
collection PubMed
description In patients with symptomatic COPD, severe/very severe airflow limitation, and a history of one moderate (and no severe) exacerbation, ICS-containing triple therapy significantly reduces exacerbation risk overall versus single or double maintenance therapy http://ow.ly/VgJC30o9pXC
format Online
Article
Text
id pubmed-6853799
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-68537992019-11-19 Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation Singh, Dave Fabbri, Leonardo M. Corradi, Massimo Georges, George Guasconi, Alessandro Vezzoli, Stefano Petruzzelli, Stefano Papi, Alberto Eur Respir J Agora In patients with symptomatic COPD, severe/very severe airflow limitation, and a history of one moderate (and no severe) exacerbation, ICS-containing triple therapy significantly reduces exacerbation risk overall versus single or double maintenance therapy http://ow.ly/VgJC30o9pXC European Respiratory Society 2019-05-18 /pmc/articles/PMC6853799/ /pubmed/30792343 http://dx.doi.org/10.1183/13993003.00235-2019 Text en Copyright ©ERS 2019 https://www.ersjournals.com/user-licence http://creativecommons.org/licenses/by-nc/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Agora
Singh, Dave
Fabbri, Leonardo M.
Corradi, Massimo
Georges, George
Guasconi, Alessandro
Vezzoli, Stefano
Petruzzelli, Stefano
Papi, Alberto
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title_full Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title_fullStr Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title_full_unstemmed Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title_short Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
title_sort extrafine triple therapy in patients with symptomatic copd and history of one moderate exacerbation
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853799/
https://www.ncbi.nlm.nih.gov/pubmed/30792343
http://dx.doi.org/10.1183/13993003.00235-2019
work_keys_str_mv AT singhdave extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT fabbrileonardom extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT corradimassimo extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT georgesgeorge extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT guasconialessandro extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT vezzolistefano extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT petruzzellistefano extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation
AT papialberto extrafinetripletherapyinpatientswithsymptomaticcopdandhistoryofonemoderateexacerbation

Ejemplares similares